This message was sent to ##Email##
|
| June 24, 2020 |
| |  | | |
|
| |
CAP Today
At NYU Langone Health, pathologists and others typically not seen out front in the fight against COVID-19 became the bridge between families and the floors.
When Katherine A. Hochman, MD, associate chair for quality in the Department of Medicine at NYU Langone, contracted a mild case of COVID-19, she finally had a chance to take a step back and think. Before going into quarantine to recover, Dr. Hochman had been on the floors day in and day out attending to COVID-19 patients.
READ MORE
ASCT
For over forty years, the ASCT has been committed to its role as the collective voice for cytotechnologists!
The field is constantly evolving, and the cytotechnologist's role is expanding at a more rapid pace than ever. We are integral members of the diagnostic team, and as such, it is important to bring our needs and ideas to the forefront of an ever-changing work environment. The ASCT remains focused on providing its members with significant resources to help you stay current on critical issues involving workload, proficiency testing, licensure, continuing education, and the workforce.
Your support as an active member is essential for the ASCT to remain the only national society that solely represents cytotechnologists. Your membership and involvement directly impact our ability to serve your personal needs, as well as the needs of our profession.
We invite you to renew your membership today!
To Renew Online
Visit to www.asct.com and log into your personal account by clicking Sign In at the top of the web page and entering your user name and password. Next, click the My Membership tab.
If you forgot your user name and password, contact info@asct.com.
 |
|
The F-50 Non-Gyn Slide Processor has a liquid-based cytology system that features more cells per slide, and doesn’t need duplicate preps. The dual filtration disposable filters remove non-diagnostic material to optimize cell presentation. Cells of interest are transferred to the slide in a homogenous thin-layer cell deposit. Throughput: 50 samples/hr.
|
|
| Date |
Event |
Location |
More information |
June 2020 |
Soft Tissue and Bone FNA
|
Your PC |
Dr. Benjamin Witt
Associate Professor of Anatomic Pathology
University of Utah/ARUP Laboratories
Salt Lake City, Utah
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC) Cell Blocks Basics Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
Document Control for Cytopathology Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench
|
Your PC |
Details |
CNN
Need another reason to get off the couch and get moving while cooped up during the coronavirus epidemic?
Here's a killer one: Too much sitting can raise your risk for cancer, according to a new study published recently in JAMA Oncology.
READ MORE
Clinical Advisor
Implementation of a human papillomavirus (HPV) vaccine tool-kit is an effective way to increase vaccination rates among adolescents, according to results of a poster presented virtually at the National Association of Pediatric Nurse Practitioners Annual Meeting (NAPNAP 2020). The 4 Pillars Practice Transformation Program is an evidence-based tool kit that has been shown to increase HPV vaccination rates across settings, noted lead author Rachel E. Hodge, MSHS, BSN, RN, from the University of Maryland School of Nursing. Staff education was conducted and patient education materials were posted throughout the primary care clinic where the kit was implemented. The Pillars were implemented over a 10-week period.
READ MORE
Cancer Network
The FDA has approved an expanded indication for the human papillomavirus (HPV) 9-valent vaccine, recombinant (Gardasil 9) for the prevention of oropharyngeal and other head and neck cancers caused by HPV types 16, 18, 31, 33, 45, 52, and 58, according to Merck, the agent's developer. The oropharyngeal and head and neck cancer indication was approved under accelerated approval based on the effectiveness Gardasil 9 has demonstrated in preventing HPV-related anogenital disease. However, continued approval for this indication may be dependent upon verification and description of clinical benefit in a confirmatory trial, which is currently underway.
READ MORE
Medical Xpress
Social media keeps us connected to one another, but it also influences our beliefs. Now, a new study from the University of Missouri finds that social media use can lead parents to incorrectly believe the human papillomavirus (HPV) vaccine could be lethal in their children.
READ MORE
|
|
|
|
|
| |
Renal Urology News
Men receiving androgen deprivation therapy (ADT) for prostate cancer (PCa) appear to be at lower risk for infection by the coronavirus that causes COVID-19, according to a new report.
In a study of men with PCa in Veneto, an Italian region especially hard hit by COVID-19, only 4 of the 5273 patients receiving ADT became infected with the SARS-CoV-2 coronavirus compared with 114 of the 37,161 not receiving ADT.
READ MORE
News-Medical
Kobe University and System Instruments Co., Ltd. researchers have developed TearExo®; new technology to detect breast cancer using the exosomes found in tears as biomarkers. Exosomes are a subtype of extracellular vesicles.
READ MORE
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
